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Abstract
Chromium is a naturally occurring heavy metal found commonly in the environment in trivalent, Cr(III), and hexavalent, Cr(VI),
forms. Cr(VI) compounds have been declared as a potent occupational carcinogen among workers in chrome plating, stainless steel, and
pigment industries. The reduction of Cr(VI) to Cr(III) results in the formation of reactive intermediates that together with oxidative stress
oxidative tissue damage and a cascade of cellular events including modulation of apoptosis regulatory gene p53, contribute to the
cytotoxicity, genotoxicity and carcinogenicity of Cr(VI)-containing compounds. On the other hand, chromium is an essential nutrient
required to promote the action of insulin in body tissues so that the body can use sugars, proteins and fats. Chromium is of significant
importance in altering the immune response by immunostimulatory or immunosuppressive processes as shown by its effects on T and B
lymphocytes, macrophages, cytokine production and the immune response that may induce hypersensitivity reactions. This review gives
an overview of the effects of chromium on the immune system of the body. 4 2002 Federation of European Microbiological Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
A large number of biologically active substances, includ-
ing heavy metals, may have direct, primary or secondary
e¡ects on the immune system and are of interest to path-
ologists, immunologists and toxicologists. Various metals
are responsible for many biochemical, immunological and
physiological activities of the body as micronutrients. But
some of them can give rise to disordered functions of the
immune system resulting in increased susceptibility to in-
fection, a variety of hypersensitivity reactions, autoim-
mune diseases and neoplasia. Heavy metals are of signi¢-
cant importance in altering the immune response by
immunostimulatory or immunosuppressive mechanisms.
Chromium is a naturally occurring heavy metal found
in the environment commonly in trivalent, Cr(III), and
hexavalent, Cr(VI), forms. The reduction of Cr(VI) to
Cr(III) results in the formation of reactive intermediates
that contribute to the cytotoxicity, genotoxicity and carci-
nogenicity of Cr(VI)-containing compounds. The major
non-occupational source of chromium for humans is
food such as vegetables, meat, urban air, hip or knee
prostheses and cigarettes [1,2]. Cr(VI) is a widely used in
industrial chemicals, extensively used in paints, metal ¢n-
ishes, steel including stainless steel manufacturing, alloy
cast irons, chrome and wood treatment. On the contrary,
Cr(III) salts such as chromium polynicotinate, chromium
chloride and chromium picolinate (CrP) are used as micro-
nutrients and nutritional supplements and have been dem-
onstrated to exhibit a signi¢cant number of health bene¢ts
in animals and humans [3].
Chromium enters the body through the lungs, gastro-
intestinal tract and to a lesser extent through skin. Inha-
lation is the most important route for occupational expo-
sure, whereas non-occupational exposure occurs via inges-
tion of chromium-containing food and water. Regardless
of route of exposure Cr(III) is poorly absorbed whereas
Cr(VI) is more readily absorbed. Further, absorption of
Cr(VI) is poorer by oral route, it is thus not very toxic
when introduced by the oral route. But chromium is very
toxic by dermal and inhalation routes and causes lung
cancer, nasal irritation, nasal ulcer, hypersensitivity reac-
tions and contact dermatitis. All the ingested Cr(VI) is
reduced to Cr(III) before entering in the blood stream.
The main routes for the excretion of chromium are via
kidney/urine and the bile/feces [1,2,4]. Cr(III) is unable
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to enter into the cells but Cr(VI) enters through membrane
anionic transporters. Intracellular Cr(VI) is metabolically
reduced to Cr(III). Cr(VI) does not react with macromo-
lecules such as DNA, RNA, proteins and lipids. However,
both Cr(III) and the reductional intermediate Cr(V) are
capable of co-ordinate, covalent interactions with macro-
molecules. Chromium is an essential nutrient required by
the human body to promote the action of insulin for the
utilization of sugars, proteins and fats. CrP has been used
as nutritional supplement; it controls blood sugar in dia-
betes and may reduce cholesterol and blood pressure lev-
els. Chromium increases insulin binding to cells, insulin
receptor number and activates insulin receptor kinase
leading to increased insulin sensitivity [3].
But high doses of chromium and long term exposure of
it can give rise to various, cytotoxic and genotoxic reac-
tions that a¡ect the immune system of the body. However,
the mechanism of the Cr(VI)-induced cytotoxicity is not
entirely understood. A series of in vitro and in vivo studies
have demonstrated that Cr(VI) induces oxidative stress
through enhanced production of reactive oxygen species
(ROS) leading to genomic DNA damage and oxidative
deterioration of lipids and proteins. A cascade of cellular
events occur following Cr(VI)-induced oxidative stress in-
cluding enhanced production of superoxide anion and hy-
droxyl radicals, increased lipid peroxidation and genomic
DNA fragmentation, modulation of intracellular oxidized
states, activation of protein kinase C, apoptotic cell death
and altered gene expression [5]. Some of the factors in
determining the biological outcome of chromium exposure
include the bioavailability, solubility of chromium com-
pounds and chemical speciation, intracellular reduction
and interaction with DNA. The chromium genotoxicity
manifests as several types of DNA lesions, gene mutations
and inhibition of macromolecular synthesis. Further, chro-
mium exposure may lead to apoptosis, premature terminal
growth arrest or neoplastic transformation. Chromium-in-
duced tumor suppressor gene p53 and oxidative processes
are some of the major factors that may determine the
cellular outcome. Studies have utilized these approaches
to understand the interrelationship between chromium-in-
duced genotoxicity, apoptosis and e¡ects on immune re-
sponse. This review gives an overview of the e¡ects of
chromium on the immune system of the body. Due to
constraint of space only a limited number of studies
have been cited.
2. E¡ects of chromium on lymphocytes
The e¡ect of chromium on lymphocytes has been inves-
tigated in several studies. Borella et al. [6] investigated the
in vitro e¡ect of toxic metals including Cr(III) and Cr(VI)
on phytohemeagglutinin-induced blastogenesis in human
lymphocytes. Cr(VI) shows a biphasic pattern, with a
stimulatory e¡ect at the lowest concentrations tested and
an inhibitory e¡ect at higher concentrations. Faleiro et al.
[7] described the e¡ect of cobalt^chromium^molybdenum
(CoCrMo) disc samples on the CD3-mediated in vitro
response of human peripheral blood T lymphocytes. Inhi-
bition of lymphocyte proliferation is observed in the pres-
ence of CoCrMo disc samples. Ultrastructural studies us-
ing scanning electron microscopy revealed that the dif-
ferences in the number of blast cells on CoCrMo discs
from a 4-day culture are consistent with the results ob-
served in the proliferation experiments. The proliferation
of both T and B cells and the production of immunoglob-
ulins by lipopolysaccharide-stimulated B cells are signi¢-
cantly inhibited by cobalt^chromium particles after intra-
peritoneal injection in mice or in in vitro experiments on
murine lymphocytes. The data indicate that the metal-in-
duced immunosuppression may be an important factor in
the development of implant-associated infection in pa-
tients with a prosthesis [8].
On the other hand, several studies have shown that
chromium salts/alloys have no e¡ect on cells of the im-
mune system. Yucesoy et al. [9] investigated the immuno-
toxic e¡ects of lead, cadmium, nickel and chromium on
natural killer (NK) cell activity in vitro. None of the metal
salts have any e¡ect on NK cell function. Similarly no
e¡ect is seen in stainless steel welders exposed to chromi-
um and nickel contained in welding fumes, for the kinetics
of cell division in culture of peripheral blood lymphocytes
[10].
3. E¡ects of chromium on macrophages
The inhalation of chromium does not a¡ect lung mor-
phology, but macrophages are enlarged, multinucleated or
vacuolated and accumulate in intra-alveolar spaces as
nodules. Higher doses of Cr(VI) depress the phagocytic
activity of alveolar macrophages and the humoral immune
response, whereas lower doses of Cr(VI) stimulate phago-
cytic activity of the alveolar macrophages and increase
the humoral immune response [11]. Macrophages can be
induced to produce nitric oxide (NO), which is important
for various functions. Tian and Lawrence [12] studied the
e¡ect of various metals including chromium and reported
that chromium does not modulate NO production by cy-
tokine (IFN-Q, TNF-K)-stimulated murine macrophages.
Chromium moderately suppresses inducible NO synthase,
which suggests that it may directly modify enzyme or co-
factor activity. Thus, metals may be pathogenic via inhi-
bition or enhancement of NO production by suppression
of defense mechanisms or induction of hypersensitivity.
Howie et al. [13] reviewed the literature on animal and
cellular models used to study the response to wear and
corrosion products of cobalt^chrome alloy implants. In-
jections of large numbers of particles in a single bolus lead
to acute in£ammation and necrosis, followed by a chronic
in£ammatory response. Macrophages are the predominant
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cell type and may persist in the tissues for years. In vitro
studies show that cobalt^chrome alloy particles induce the
release of in£ammatory mediators from macrophages be-
fore causing cell death. These mediators have signi¢cant
e¡ects on osteoblast-like cells, besides inducing bone re-
sorption. Lee et al. [14] have shown dose-dependent e¡ects
of chromium chloride and CrP on glucose uptake, super-
oxide anion (O23) production, activity of glucose-6-phos-
phate dehydrogenase and phagocytosis of Escherichia coli
by incubation of pulmonary alveolar macrophages in me-
dium in the presence or absence of insulin.
Gatta et al. [15] studied the e¡ects of dietary chromium
yeast supplementation on the immune response of rainbow
trout (Oncorhynchus mykiss). A positive in£uence is ob-
served on serum lysozyme activity in ¢sh maintained on
the high-chromium diet. Signi¢cant di¡erences are found
in the ability to phagocytose and level of respiratory burst
elicited by macrophages of ¢sh fed supplemented chromi-
um. Jain and Kannan [16] demonstrated that chromium
supplementation inhibits TNF-K secretion in U937 mono-
cytes cultured in high -glucose medium, which appears to
be mediated by its antioxidative e¡ect.
4. E¡ects of chromium on cytokines
The e¡ect of chromium on cytokines has been studied
either by administration of chromium or implantation of
prosthesis containing chromium alloy. Myers et al. [17]
studied the e¡ect of dietary CrP and recombinant porcine
growth hormone, somatotropin (rPST) administration on
growth performance and cytokine production in Land-
race-Poland China gilts. They showed that CrP-treated
swine have very high IL-6 levels while no di¡erences are
seen in plasma IL-6 from pigs treated with the rPST and
rPST+CrP. Peripheral blood mononuclear cells from CrP-
treated animals produce more IL-2 than from all other
groups.
Shumilla et al. [18] reported that pretreatment of A549
human lung carcinoma cells with non-toxic levels of
Cr(VI) inhibits TNF-K-stimulated expression of the en-
dogenous gene for IL-8 and of an NF-kappaB-driven lu-
ciferase gene construct, but not expression of urokinase, a
gene with a more complex promoter. Chromium does not
inhibit TNF-K-stimulated IkappaBalpha degradation or
translocation of NF-kappaB-binding proteins to the nu-
cleus. These data indicate that non-toxic levels of Cr(VI)
selectively inhibit NF-kappaB transcriptional competence
by inhibiting interactions with coactivators of transcrip-
tion rather than DNA binding.
Chromium e¡ects immune functions of urban women
who are exposed to chromium by vehicular tra⁄c. Serum
IgE and spontaneous in vitro production of IL-4 and
IFN-Q are higher by mononuclear blood cells of women
who are exposed to an urban environment [19].
Several studies have investigated the e¡ect of prosthesis
on the cytokine responses of the body. Horowitz et al. [20]
elucidated the mechanisms by which cobalt^chromium
particulate wear debris contribute to the aseptic loosening
of total joint prostheses. Incubation of macrophages with
cobalt chromium lead to release of TNF-K and PGE2, but
not of IL-1L or IL-6. Macrophages play a role in the
initiation of bone resorption at the interface through the
phagocytosis of cobalt chromium particles and subsequent
release of TNF-K and PGE2.
Prabhu et al. [21] have examined a number of basic
biological responses of the J774A.1 cell line, including
cell proliferation, apoptosis, cytokines secreted into the
culture supernatant (TNF-K, IL-1K, IL-6, and IL-12)
and mRNA expression of the cytokines (TNF-K, IL-1K,
IL-6, IFN-K, M-CSF and TGF-L) in response to cobalt^
chrome alloy particles (CoCr). The results indicate that the
relative contribution of CoCr particles in J774A.1 activa-
tion is negligible and a change in metabolic activity of
J774A.1 cells is observed only at higher concentrations
of CoCr particles.
Granchi et al. [22] determined whether the serum levels
of bone-resorbing cytokines (IL-1L, TNF-K, IL-6, GM-
CSF) are altered in patients with aseptic loosening of a
total hip prosthesis. The results suggest that a CoCr im-
plant releases a large amount of metal ions which could
mediate the priming or the renewal of a cell-mediated
hypersensitivity reaction. The prevalence of circulating
Thl lymphocytes accounts for both the signi¢cant increase
of TNF and the signi¢cant decrease of IL-6 in unstimu-
lated PBMC of patients, as well as the signi¢cant increase
of the ‘index of cytokine release’ after challenge with metal
ions [22].
5. E¡ects of chromium on immune response
Burton et al. [23] studied the e¡ects of supplemental
dietary chromium on immune responses of dairy cows
subjected to physical and metabolic stresses. They showed
that supplemental chromium elevates anti-ovalbumin-anti-
body responses and mitogen-stimulated blastogenic re-
sponses of peripheral blood mononuclear cells. Another
study shows that supplemental chromium had no bene¢-
cial e¡ect on health status, mastitis-related parameters or
neutrophil phagocytic activity of dairy cows [24]. Van de
Ligt et al. [25] have studied the e¡ect of chromium tripi-
colinate supplementation of diet on porcine immune re-
sponse during the postweaning period and found no e¡ect
on the performance and immune status.
Khangarot et al. [26] studied the e¡ects of subtoxic lev-
els of chromium on humoral and cell-mediated immune
responses, blood parameters, susceptibility to bacterial
(Aeromonas hydrophila) infection and macrophage activity
in the freshwater air-breathing Asian cat¢sh, Saccobran-
chus fossilis. Fish exposed to chromium have lower spleen
weight, lower antibody titer, reduced numbers of splenic
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plaque-forming cells and higher counts of splenic lympho-
cytes. Di¡erential leukocyte counts revealed that chromi-
um exposure causes a signi¢cant decrease in large and
small lymphocytes, whereas neutrophils and thrombocytes
increase. Concanavalin A-induced proliferation of splenic
and pronephric lymphocytes is decreased. The eye-allo-
graft rejection time is increased. Fish exposed to chromi-
um exhibit higher susceptibility to A. hydrophila infection.
The phagocytic activity of splenic and pronephros macro-
phages is signi¢cantly decreased. Arunkumar et al. [27]
injected African mouth breeder Oreochromis mossambicus
(Peters) intraperitoneally with Cr(III) and Cr(VI) and sub-
sequently immunized with bovine serum albumin. Both
forms of chromium suppress the antibody response, with
Cr(VI) being more suppressive than Cr(III). Reduction in
spleen weight, splenocyte number and the percentage of
blood lymphocytes is observed following administration
of both forms of chromium. An early study done on hu-
man cells by Borella et al. [28], who studied the e¡ects of
Cr(VI) and other metals on cultured human lymphocytes
found that chromium induces reductions in both blasto-
genesis and immunoglobulin production in relation to its
capability to enter the cells.
6. Chromium-induced hypersensitivity reactions
Chromium induces two types of hypersensitivity reac-
tions: type I, anaphylactic type, and type IV, the de-
layed-type hypersensitivity. Chromium is one of the most
common skin sensitizers in the general population. Such
exposure, for example, involves handling cement, tanning
of leather, chromium plating. Cr(VI) readily transverses
cell membrane and undergoes intracellular reduction to
Cr(III) by forming a conjugate with proteins to act as
complete antigen. Circulating antibodies against Cr(III)
but not against Cr(VI) have been identi¢ed in sensitized
animals [29]. Dermal exposure of chromium produces ir-
ritant and allergic contact dermatitis [29,30^33]. It is ob-
served that keratinocytes are the ¢rst target cells a¡ected
by chromium in causing contact dermatitis. These cells can
be directly activated through the expression of the mem-
brane antigen ICAM-I, a ligand of the leucocytes antigen
LFA-I and the production of cytokines including a signi¢-
cant release of TNF-K. These ¢ndings indicate that chro-
mium may be able to induce an aggressive cellular e¡ect
and may play a major role in keratinocyte activation dur-
ing contact dermatitis [34]. Development of allergic con-
tact dermatitis by exposure to chromium has been re-
ported in several studies. Thomas et al. [35] reported a
case of a 37-year-old man who developed an aseptic intol-
erance reaction to a chromium^cobalt alloy. Skin testing
gave a delayed-type reaction to dichromate. Immunohis-
tology reveal a monocytic and dense T-cell in¢ltrate. The
latter, instead of being random, showed an oligoclonal
T-cell receptor rearrangement. The actual tissue mRNA
expression for IL-4, IL-6, and IFN-Q was visualized by
reverse transcription-polymerase chain reaction. This indi-
cated a Th1-type mediator expression (IL-6 and IFN-Q but
not IL-4). Chromium may also be less commonly involved
in immediate or type I hypersensitivity reactions. Cases of
asthma with an immediate or delayed response have been
observed following occupational exposure to chromium
[36]. Hassmanova et al. [37] have studied occupational
diseases caused by chromium and its compounds. They
have reported perforations of the nasal septum, bronchial
asthma, allergic rhinitis and contact allergic eczemas and
an exceptional ¢nding of a chromium ulcer (pigeonneaux)
on the lower extremity of a builder.
7. Chromium-induced cell death
Chromium is known to have cytotoxic e¡ects on cells.
Vasant et al. [38] have shown that apoptosis is the mode of
cell death of human lymphocytes in the presence of both
Cr(V) and Cr(VI). Pretreatment of cells with antioxidants,
before exposure to chromium(V) complexes, reverses apo-
ptosis partially. The possibility has been suggested for the
formation and implication of reactive oxygen species in
Cr(V)-induced apoptosis of human lymphocyte cells. The
studies of Carlisle et al. [39] show that chromium-induced
apoptosis of normal diploid human lung ¢broblasts is p53
dependent.
8. Mechanisms of action of chromium on cells of
immune system
Easy availability, convenient to handle and maintain in
vitro in culture make lymphocyte and macrophage ideal
cells to study the mechanism of cytotoxicity and genotox-
icity and, thus, the mechanism of e¡ects on immune func-
tions of body. Initial studies used DNA strand breaks and
sister-chromatid exchange (SCE) in blood lymphocytes to
investigate the toxicity of chromium. Gao et al. [40] incu-
bated human lymphocytes with Cr(VI) at 37‡C for 3 h and
showed a dose-dependent increase in DNA strand breaks
without concurrent cytotoxicity. In contrast, Cr(III) fails
to induce DNA strand breaks at subcytotoxic concentra-
tions. Gennart et al. [41] determined SCE in blood lym-
phocytes in 26 male workers occupationally exposed to
chromium, cobalt and nickel dust and in 25 controls
matched for age and smoking habits. An analysis of var-
iance on the SCE rank values reveal that both exposure
status (exposed persons vs. controls) and smoking habits
(smokers and former smokers vs. never smokers) have a
statistically signi¢cant e¡ect.
Katsi¢s et al. [42] and Lai et al. [43] compared the e¡ect
of chromium and Ni^Cr on SCE in lymphocytes to obtain
an understanding of the mutagenic e¡ect of Cr(VI) in
humans. The data indicate that antagonism may occur
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when human lymphocytes are exposed simultaneously to
Ni(II) and Cr(VI), suggesting an explanation for epide-
miological studies reporting con£icting results for cytoge-
netic e¡ects in lymphocytes of workers exposed to chro-
mium and nickel. On the other hand, additive damaging
e¡ect of chromium and curcumin on DNA of human lym-
phocytes and gastric mucosa (GM) has been reported by
Blasiak et al. [44] by using the alkaline single cell gel elec-
trophoresis (comet assay). Moreover, curcumin itself can
damage DNA of these cells and the total e¡ect of chro-
mium and curcumin is additive.
Blasiak and Kowalik [45] compared the e¡ects of
Cr(III) and Cr(VI) on the DNA damage in human lym-
phocytes using the comet assay. The e¡ect is dose depen-
dent. Treated cells recover within a 120-min incubation.
Cr(III) causes greater DNA migration than Cr(VI). Cata-
lase, an enzyme inactivating hydrogen peroxide, decreases
the extent of DNA damage induced by Cr(VI), but not
that induced by Cr(III). Lymphocytes exposed to Cr(VI)
and treated with endonuclease III, which recognizes oxi-
dized pyrimidines, displayed a greater extent of DNA
damage than those not treated with the enzyme. Such an
e¡ect is not observed when Cr(III) is tested. The results
obtained suggest that reactive oxygen species and hydro-
gen peroxide may be involved in the formation of DNA
lesions by Cr(VI). The comet assay did not indicate the
involvement of oxidative mechanisms in the DNA-damag-
ing activity of Cr(III) and due to its binding to cellular
ligands it may play a role in its genotoxicity. Trzeciak et
al. [46] studied chromium-induced damage to DNA in
both the GM cells and lymphocytes by the comet assay.
The e¡ect induced by K2Cr2O7 in GM cells is similar to
that seen in the lymphocytes.
Recent in vitro and in vivo studies have investigated the
e¡ect of Cr(VI) on human PBMC, chronic myelogenous
leukemic K562 cells and J774A.1 murine macrophage cells
and on female C57BL/6Ntac and p53-de¢cient C57BL/
6TSG p53 mice using comet assay, laser scanning confocal
microscopy and £ow cytometry. [5,47]. The ¢ndings dem-
onstrate that chromium induces an oxidative stress that
results in oxidative deterioration of biological macromole-
cules. Chromium undergoes redox cycling, resulting in en-
hanced production of reactive oxygen species such as
superoxide ion, hydroxyl radicals and hydrogen peroxide.
These reactive oxygen species result in increased lipid per-
oxidation, enhanced excretion of urinary lipid metabolites,
modulation of intracellular oxidized states, DNA damage,
membrane damage, altered gene expression and apoptosis.
Enhanced production of nuclear factor-kappaB and acti-
vation of protein kinase C occur. Furthermore, the p53
tumor suppressor gene is involved in the cascade of events
associated with the toxicities of these cations. Taken to-
gether, oxidative stress and oxidative tissue damage and a
cascade of cellular events including modulation of apopto-
sis regulatory gene p53 are involved in Cr(VI)-induced
toxicity and carcinogenesis [5,47].
9. Conclusions
Chromium is a naturally occurring heavy metal and is
an essential micronutrient required to promote the action
of insulin in body tissues so that the body can use sugars,
proteins and fats. Clinical and laboratory evidences indi-
cate that hexavalent chromium, Cr(VI), is responsible for
most of the toxic actions. Chromium is very toxic by in-
halation and dermal route and causes lung cancer, nasal
irritation, nasal ulcer and hypersensitivity reactions like
contact dermatitis and asthma. Chromium a¡ects various
components of the immune system and may result in im-
munostimulation or immunosuppression. The reduction of
Cr(VI) to Cr(III) results in the formation of reactive in-
termediates that together with oxidative stress and oxida-
tive tissue damage and a cascade of cellular events includ-
ing modulation of apoptosis regulatory gene p53
contribute to the cytotoxicity, genotoxicity and carcinoge-
nicity of Cr(VI)-containing compounds. Exposure to
Cr(VI) can result in various point mutations in DNA
and to chromosomal damage, as well as to oxidative
changes in proteins. The relative importance of the chro-
mium ions and of the free oxidizing radicals that may
generate in causing cancers and allergic sensitization re-
main to be elucidated.
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